Entero Therapeutics, Stock Target Price and Analyst Consensus

ENTO Stock   0.61  0.11  22.00%   
The current analyst and expert consensus on Entero Therapeutics, is Buy, with no strong buy opinions. The current projected Entero Therapeutics, target price consensus is 36.00 with 1 analyst opinions. Check out Macroaxis Advice on Entero Therapeutics, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.
The most common way Entero Therapeutics, analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Entero Therapeutics, executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Entero Therapeutics,. We encourage you to use your own analysis of Entero Therapeutics, to validate this buy or sell advice. Entero Therapeutics, buy-or-sell recommendation module provides average expert sentiment on the projected Entero Therapeutics, target price to derive its highest and lowest estimates based on projected price volatility of 7.9269.
Lowest Forecast
32.76
Highest Forecast
39.96
Target Price
36
As of the 4th of March 2025, Gross Profit is likely to drop to about (35.3 K). At this time, Entero Therapeutics,'s Common Stock Shares Outstanding is very stable compared to the past year. As of the 4th of March 2025, Liabilities And Stockholders Equity is likely to grow to about 7.4 M, while Net Debt is likely to drop (2.7 M).
  
It's important to approach Entero Therapeutics,'s target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Entero Therapeutics, price targets

Entero Therapeutics,'s stock target price is an estimate of its future price, usually made by analysts. Using Entero Therapeutics,'s target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Entero Therapeutics,'s target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Entero Therapeutics,'s stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Entero Therapeutics, Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Entero Therapeutics, is a key component of Entero Therapeutics, valuation and have some predictive power on the future returns of a Entero Therapeutics,.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Entero Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.618.42
Details
Intrinsic
Valuation
LowRealHigh
0.559.4417.25
Details
Naive
Forecast
LowNextHigh
0.010.608.41
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.28-0.28-0.28
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
ESG Investing Idea
ESG Investing
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 30 shares
Momentum Idea
Momentum
Invested over 60 shares
Banking Idea
Banking
Invested over 30 shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Electronic Equipment Idea
Electronic Equipment
Invested over 20 shares
When determining whether Entero Therapeutics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entero Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entero Therapeutics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entero Therapeutics, Stock:
Check out Macroaxis Advice on Entero Therapeutics, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..